The relationship between COVID-19 and hyperglycemia: screening and monitoring hospitalized patients.

Publication date: Aug 31, 2024

Elevated blood glucose concentration, also known as hyperglycemia, has been identified as a significant factor influencing the prognosis of COVID-19, alongside the impact of the SARS-CoV-2 infection itself. This research is a cross-sectional investigation that examined the relationship between COVID-19 and hyperglycemia in patients admitted to Afzalipour Hospital in Kerman, Iran, from July to September 2021. A standardized data sheet was used to capture demographic data (age, gender) and laboratory information (blood sugar, arterial blood oxygen saturation, and C-reactive protein (CRP)) upon admission. The present research evaluated a total of 300 individuals diagnosed with COVID-19, with an average age of 50. 19ā€‰+/-ā€‰15. 55 years. Among these patients, the majority were male, accounting for 51. 67% of the total. Hyperglycemia was seen in 21. 67% of patients, but less than 20% had new-onset diabetes. Individuals exhibiting hyperglycemia were typical of advanced age (Pā€‰

Concepts Keywords
Accounting COVID-19
Diabetes Hyperglycemia
Iran New-onset diabetes
July Prognosis

Semantics

Type Source Name
disease MESH COVID-19
disease MESH hyperglycemia
disease IDO blood
drug DRUGBANK Dextrose unspecified form
pathway REACTOME SARS-CoV-2 Infection
drug DRUGBANK Oxygen
disease MESH Long Covid

Original Article

(Visited 1 times, 1 visits today)